Christophe

EQS-News: Affluent Medical strengthens management team to advance its development

Retrieved on: 
Lundi, juillet 17, 2023
Edwards, Christophe, IPO, CET, Fresenius (company), Pathology, Merck Group, Vregille, Doctor of Philosophy, CDO, Euronext Paris, Medtronic, Patient, CFO, Knowledge, Growth, Wealth, Johnson & Johnson, Regulatory affairs, VTC, Aix-en-Provence, Medtech, Covidien, BD, Urinary incontinence, Pharmaceutical industry, Management

Sébastien Ladet, CEO of Affluent Medical, commented: "I am delighted to welcome Christophe de Vregille and Benjamin Renault to the Affluent Medical management team at a time when we are approaching several decisive stages in the deployment of our development strategy.

Key Points: 
  • Sébastien Ladet, CEO of Affluent Medical, commented: "I am delighted to welcome Christophe de Vregille and Benjamin Renault to the Affluent Medical management team at a time when we are approaching several decisive stages in the deployment of our development strategy.
  • Benjamin brings a wealth of experience and knowledge in medical device development, which will be instrumental in preparing for commercialization and our expansion on international markets."
  • Benjamin Renault has over 15 years' experience in the development and international deployment of medical devices.
  • Overview of Affluent Medical’s management and leadership team:
    Christophe Giot, M.D., Chief Medical Officer and Vice President Clinical Affairs (Edwards, Terumo, Sanofi)
    Céline Buard, Marketing Director (Johnson & Johnson, BD, Eyetech Care)
    Eric Jague, Director of Regulatory Affairs (Medtronic, Fresenius Kabi)

Affluent Medical strengthens management team to advance its development.

Retrieved on: 
Lundi, juillet 17, 2023
Edwards, Christophe, IPO, CET, Fresenius (company), Pathology, Merck Group, Vregille, Doctor of Philosophy, CDO, Euronext Paris, Medtronic, Patient, Regulatory News Service, CFO, Knowledge, Growth, Wealth, Johnson & Johnson, Regulatory affairs, VTC, Aix-en-Provence, Medtech, Covidien, BD, Urinary incontinence, Risk management, Pharmaceutical industry, Management

Affluent Medical strengthens management team to advance its development.

Key Points: 
  • Affluent Medical strengthens management team to advance its development.
  • Sébastien Ladet, CEO of Affluent Medical comments: "I am delighted to welcome Christophe de Vregille and Benjamin Renault to the Affluent Medical management team at a time when we are approaching several decisive stages in the deployment of our development strategy.
  • Benjamin Renault has over 15 years' experience in the development and international deployment of medical devices.
  • Overview of Affluent Medical’s management and leadership team:
    Christophe Giot, M.D., Chief Medical Officer and Vice President Clinical Affairs (Edwards, Terumo, Sanofi)
    Céline Buard, Marketing Director (Johnson & Johnson, BD, Eyetech Care)
    Eric Jague, Director of Regulatory Affairs (Medtronic, Fresenius Kabi)

American Express Announces Retirement of Chief Financial Officer Jeffrey C. Campbell and Names Deputy Chief Financial Officer Christophe Le Caillec as Successor

Retrieved on: 
Mardi, juin 27, 2023
Banking, Professional Services, Finance, Christophe, Risk, Vice, Partnership, McKesson Corporation, Express company, Business, Executive Committee, Corporation, CFO, Growth, EPS, Railway Executive Committee, Family, NYSE, Express, Management, American Express, American Airlines

American Express Company (NYSE:AXP) today announced that Jeffrey C. Campbell, Vice Chairman and Chief Financial Officer, has decided to retire from the company.

Key Points: 
  • American Express Company (NYSE:AXP) today announced that Jeffrey C. Campbell, Vice Chairman and Chief Financial Officer, has decided to retire from the company.
  • He will step down as the company’s CFO as of August 14, 2023, at which time Christophe Le Caillec, Deputy Chief Financial Officer, will succeed him as CFO, and join the American Express Executive Committee.
  • Prior to American Express, Mr. Campbell served as CFO of McKesson and American Airlines.
  • Le Caillec works closely with both Mr. Squeri and Mr. Campbell to drive the company’s financial success in executing the growth plan.

RGI Announces Appointment of Patricia Fouqueray as Country Manager of KAPIA-RGI

Retrieved on: 
Jeudi, juin 22, 2023
Professional Services, Technology, Other Professional Services, Other Technology, Insurance, Software, Heart, Christophe, Aladdin, Multimedia, BlackRock, Acquisition, Growth, RGI, Management, Adviser

RGI Group, the European software solutions leader in insurance industry, announces the appointment of Patricia Fouqueray as new France Country Manager.

Key Points: 
  • RGI Group, the European software solutions leader in insurance industry, announces the appointment of Patricia Fouqueray as new France Country Manager.
  • Patricia Fouqueray succeeds Christophe Quesne, who will take on the role of Advisor of RGI Group.
  • Since 2018 Patricia has been the Managing Director of BlackRock Solutions for the Aladdin clients in France, Belgium, Luxembourg, Italy and Spain.
  • Patricia Fouqueray commented: “I am excited to join RGI Group and its highly experienced team to stretch and consolidate the growth on the French insurance industry.

Common Energy Announces Competitive Wins; Closes In On 400MW Under Management; Promotes New Chief Operating Officer

Retrieved on: 
Mercredi, juin 14, 2023
Other Energy, Software, Utilities, Oil, Gas, Internet, Alternative Energy, Energy, Technology, Insurance, Christophe, Telecommunications, SAAS, Carbon, McKinsey & Company, Parable of those who associate partners with God, Growth, ROI, Common, Renewable energy

Community solar provider Common Energy today announced key competitive wins across multiple states including Illinois, Maryland and Oregon.

Key Points: 
  • Community solar provider Common Energy today announced key competitive wins across multiple states including Illinois, Maryland and Oregon.
  • These transactions expand Common Energy’s client base of developers, which now includes five of the leading community solar developers/IPPs in the country.
  • Under the agreements, Common Energy will acquire subscribers for the projects, and manage the subscriptions under long-term management contracts.
  • “The strength of our platform and execution continues to drive growth and market share gains,” said Richard Keiser, founder and CEO of Common Energy.

IFF Names New President of Nourish and Introduces Leadership Structure Aligned to New Operating Model

Retrieved on: 
Mercredi, juin 7, 2023
Cosmetics, Retail, Chemicals, Plastics, Manufacturing, Specialty, Food, Beverage, Christophe, University, ICI, Kellogg, Engineering, Marketing, DuPont, CPG, Registered trademark symbol, Faculty of Management Studies – University of Delhi, All rights reserved, Herriott, Nutrition and Health, Science, Creativity, Personal care, Strategic management, Paweł Strzelecki, National Institutes of Technology (India), Corporation, Osaka Titanium Technologies, Zeneca, Growth, Cereal, International Flavors & Fragrances, NYSE, Odor, Drug, Management, Perfume, IFF, Health, Beach nourishment

IFF today also announced the leadership structure to support the transition to a new operating model as part of the company’s transformation strategy.

Key Points: 
  • IFF today also announced the leadership structure to support the transition to a new operating model as part of the company’s transformation strategy.
  • IFF expects its new operating model to be in effect by the beginning of 2024.
  • As President, Nourish, Arora, will lead IFF’s Food and Beverage categories when the operating model is in full effect in the new year.
  • “Our evolution to a category-aligned operating model is a pivotal moment for IFF,” said Frank Clyburn, IFF CEO.

Eutelsat Appoints Christophe Caudrelier as Chief Financial Officer

Retrieved on: 
Jeudi, novembre 24, 2022
Data Management, Consumer Electronics, Carriers and Services, Technology, Security, Other Technology, Satellite, Telecommunications, Networks, Audio, Video, Internet, DTH, Investment, Eutelsat, Arthur Andersen, Government, Partner, ESCP, Connectivity, CFO, Digital divide, École, Virtual CFO, Woman, Valeo, Mobile broadband, Christophe, Euronext Paris, ETL, Management, Communications satellite

Eutelsat Communications (Euronext Paris: ETL) (Paris:ETL) today announced the appointment of Christophe Caudrelier as Chief Financial Officer, effective at the latest on 2nd January 2023.

Key Points: 
  • Eutelsat Communications (Euronext Paris: ETL) (Paris:ETL) today announced the appointment of Christophe Caudrelier as Chief Financial Officer, effective at the latest on 2nd January 2023.
  • His appointment follows the announcement by Sandrine Tran that she is stepping down as Chief Financial Officer to move on to other professional projects.
  • I believe that Christophes experience in strongly business-oriented finance and his international background will be valuable assets for Eutelsat, Eutelsat's Chief Executive Officer Eva Berneke explained.
  • Christophe Caudrelier added: I am very pleased and proud to join Eutelsat as Chief Financial Officer.

DEM BioPharma Establishes Leadership Team with Appointment of Nenad Grmusa as CEO and Christophe Quéva, Ph.D., as CSO

Retrieved on: 
Mardi, septembre 27, 2022
General Health, Other Health, Health, Pharmaceutical, Oncology, International economics, VP, EM, Doctor of Philosophy, Fred Hutchinson Cancer Research Center, Whitehead Institute, CEI, Brandeis University, Center, Research, CRISPR, Â, Innovation, Neoplasm, Phagocytosis, West Virginia University, Company, Senior, GSK, Macrophage, Industry, Therapy, University of Lille Nord de France, DRS, Head, Virginia University, History, Johns Hopkins School of Medicine, Amgen, AstraZeneca, Christophe, Drug development, Takeda, Harvard Medical School, Stanford University, Gilead Sciences, Genomics, R, DEM, Multimedia, University, SVP, Drug discovery, Management, Fine chemical, Vaccine, Immunology, Life

The company simultaneously announced the prior appointment of Loise Francisco-Anderson, Ph.D., as SVP and Head of Biology.

Key Points: 
  • The company simultaneously announced the prior appointment of Loise Francisco-Anderson, Ph.D., as SVP and Head of Biology.
  • Mr. Grmusa, Dr. Quva and Dr. Francisco-Anderson join experienced industry leader John McCabe who serves as Chief Financial Officer and Chief Operating Officer.
  • I am thrilled to join DEM Bio and to work alongside this world-class team of leaders in the emerging and highly promising field of innate immune system checkpoint inhibitors, said Mr. Grmusa.
  • Mr. Grmusa brings 20 years of industry experience in business development, pharmaceutical portfolio management, R&D finance and financial planning and analysis.

Valaris Announces New Executive Leadership Appointments

Retrieved on: 
Jeudi, mai 26, 2022
Oil, Gas, Natural Resources, Energy, Other Transport, Maritime, Logistics, Supply Chain Management, Transport, Mining, Minerals, Senior, Norton Rose Fulbright, Social Security Government Pension Offset, Company, Public health, Pride International, Terrorism, Annual report, Financial condition report, Result, Contract, Analysis, Public expenditure, Solution, Bankruptcy, Associate, ENSCO, Inc., Limited, Investor relations, Decision-making, COVID-19, Politics of Bermuda, Securities Act of 1933, Securities Exchange Act of 1934, Industry, Weather, Marketing, Time, Forward-looking statement, Christophe, FID, Safety, General counsel, Technology, Federal Lands Jobs and Energy Security Act, Lufkin Industries, Transocean, Maintenance, Security (finance), Part Two, Bermuda, CFO, Phrase, NYSE, Social, Lyne, Management, Biophysical environment, Valaris, Seadrill

Valaris Limited (NYSE: VAL) ("Valaris" or the "Company") today announced the appointment of three new members of the Valaris Executive Management Committee.

Key Points: 
  • Valaris Limited (NYSE: VAL) ("Valaris" or the "Company") today announced the appointment of three new members of the Valaris Executive Management Committee.
  • I am thrilled to welcome three proven, high-performing leaders to the Valaris Executive Management Committee, said Anton Dibowitz, President and Chief Executive Officer of Valaris.
  • The Valaris Executive Management Committee and Board are very appreciative of their ongoing contributions, added Mr. Dibowitz.
  • Valaris maintains an unwavering commitment to safety, operational excellence, and customer satisfaction, with a focus on technology and innovation.

Mediliant Group Welcomes Christophe Schindler as New CFO

Retrieved on: 
Mardi, avril 26, 2022
Christopher Schindler, MDI, Trauma, Extremities, European Medical Devices Industry Group, Risk management, Le Locle, CH, CFO, Growth, Solution, Medtech, Forecasting, CMO, Management, Pharma, Biotechnology, Spine, Christophe

LE LOCLE, Switzerland, April 26, 2022 /PRNewswire-PRWeb/ -- Leaders in medical device contract manufacturing, Mediliant Group, has today announced the addition of Christophe Schindler as their new Chief Financial Officer (CFO). The addition of Mr. Schindler was a part of the strategic growth plan for the group as they continue to expand and strengthen the organization's leadership team.

Key Points: 
  • LE LOCLE, Switzerland, April 26, 2022 /PRNewswire-PRWeb/ -- Leaders in medical device contract manufacturing, Mediliant Group, has today announced the addition of Christophe Schindler as their new Chief Financial Officer (CFO).
  • The addition of Mr. Schindler was a part of the strategic growth plan for the group as they continue to expand and strengthen the organization's leadership team.
  • - Christophe Schindler
    The Mediliant Group has calculated growth plans that are targeted primarily through mergers and acquisitions.
  • For more information about Christophe Schindler and the Mediliant Group visit Mediliant.com.